Liang Yang

Liang Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2021 in Nanomedicine
Verified
Journal Article
Closed access
BZBo'cheng Zhang
Bo'cheng Zhang
XTXiaoyuan Tian
Xiaoyuan Tian
ZQZhenan Qu
Zhenan Qu
JLJiaming Liu
Jiaming Liu
LYLiang Yang
Liang Yang
WZweiguo zhang
weiguo zhang
Background: Some studies have reported results from the use of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) to treat osteoarthritis (OA). Objective: To evaluate the efficacy of MS...

3 August 2026 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
XZXiangqian Zou
Xiangqian Zou
YMYibo Ma
Yibo Ma
ZYZhi Yang
Zhi Yang
RZRenjie Zhang
Renjie Zhang
CTChristine Tao
Christine Tao
LYLiang Yang
Liang Yang
Osteoarthritis (OA) is closely associated with mitochondrial dysfunction, but whether mitochondrial dynamics restoration can serve as an effective therapeutic entry point remains unclear. This study investigated the mitochondrial fusion promoter M1 (MFPM1) as a modulator of mitochondrial dynamics in OA and explored its target-associated mechanism. Bioinformatic and transcriptomic analyses linked OA progression and MFPM1 activity to mitochondrial dynamics, oxidative stress, inflammatory activation, apoptosis, and extracellular matrix (ECM) homeostasis. In OA-like chondrocytes, MFPM1 restored the balance between DNM1L/DRP1-associated fission signaling and MFN2/OPA1-associated fusion machinery, accompanied by recovery of mitochondrial energy metabolism and redox homeostasis and attenuation of inflammatory and apoptotic injury. Target prediction, molecular docking, molecular dynamics simulation, and CETSA identified GSK3B as a prioritized MFPM1 target, while GSK3B overexpression weakened the mitochondrial and cartilage-protective effects of MFPM1, supporting its functional involvement. MFPM1 further preserved ECM homeostasis and alleviated OA progression. These findings identify mitochondrial dynamics remodeling as a mechanistic entry point for OA intervention and support MFPM1 as a mitochondria-centered therapeutic candidate.


12 May 2026 in Cellular Signalling
Verified
Journal Article
Closed access
GZGuohua Zhang
Guohua Zhang
DLDongpei Liu
Dongpei Liu
SLShiwei Liu
Shiwei Liu
XZXiangqian Zou
Xiangqian Zou
LYLiang Yang
Liang Yang